Company · CIK 0001088856 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
CORCEPT THERAPEUTICS INC · CORT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 18, 7:47 pm EDT | Gary Charles RobbChief Business Officer | 17,493 | $8.27 | $144,667 | 31,156 | — | |
| Sep 16, 2026 SForm 4 → | Sep 18, 7:53 pm EDT | Roberto Wandenkolk VieiraPresident, Oncology | 296 | $100.82 | $29,843 | 3,946 | −6.98% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 16, 4:30 pm EDT | James N WilsonDirector | 10,000 | $110.69 | $1,106,940 | 1,064,543 | −0.93% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 16, 4:30 pm EDT | Joseph Douglas LyonSee Remarks | 10,000 | $113.49 | $1,134,947 | 5,683 | −63.8% | 10b5-1 |
| Sep 14, 2026 MForm 4 → | Sep 16, 4:30 pm EDT | Joseph Douglas LyonSee Remarks | 10,000 | $12.99 | $129,863 | 15,683 | — | 10b5-1 |
| Sep 2, 2026 SForm 4 → | Sep 3, 9:02 pm EDT | Roberto Wandenkolk VieiraPresident, Oncology | 58,333 | $110.76 | $6,460,766 | 4,242 | −93.2% | 10b5-1 |
| Sep 1, 2026 AForm 4 → | Sep 3, 9:16 pm EDT | William GuyerChief Development Officer | 328 | $113.38 | $18,594 | 4,313 | — | |
| Sep 1, 2026 SForm 4 → | Sep 3, 9:16 pm EDT | Sean MaduckSee Remarks | 25,000 | $114.43 | $2,860,737 | 9,755 | −71.9% | 10b5-1 |
| Sep 1, 2026 AFMForm 4 → | Sep 3, 9:16 pm EDT | Sean MaduckSee Remarks | 25,417 | $9.38 | $237,022 | 9,938 | — | 10b5-1 |
| Sep 1, 2026 AFForm 4 → | Sep 3, 9:06 pm EDT | Atabak MokariChief Financial Officer | 378 | $113.38 | $27,211 | 16,304 | — | |
| Sep 1, 2026 AFForm 4 → | Sep 3, 9:03 pm EDT | Gary Charles RobbChief Business Officer | 419 | $113.38 | $28,912 | 13,663 | — | |
| Sep 1, 2026 AFMForm 4 → | Sep 3, 9:02 pm EDT | Roberto Wandenkolk VieiraPresident, Oncology | 58,711 | $22.01 | $1,288,954 | 62,575 | — | 10b5-1 |
| Sep 1, 2026 AFForm 4 → | Sep 3, 9:00 pm EDT | Joseph Douglas LyonSee Remarks | 332 | $113.38 | $22,903 | 5,683 | — | |
| Aug 26, 2026 SForm 4 → | Aug 28, 4:30 pm EDT | Kimberly ParkDirector | 26,685 | $122.55 | $3,270,169 | 0 | −100% | |
| Aug 26, 2026 FMForm 4 → | Aug 28, 4:30 pm EDT | Kimberly ParkDirector | 33,315 | $24.30 | $809,428 | 26,685 | — | |
| Aug 25, 2026 SForm 4 → | Aug 27, 4:30 pm EDT | Sean MaduckSee Remarks | 30,955 | $125.58 | $3,887,320 | 9,755 | −76.0% | 10b5-1 |
| Aug 25, 2026 MForm 4 → | Aug 27, 4:30 pm EDT | Sean MaduckSee Remarks | 30,955 | $11.35 | $351,339 | 40,710 | — | 10b5-1 |
| Aug 18, 2026 SForm 4 → | Aug 20, 4:30 pm EDT | David L MahoneyDirector | 103,606 | $118.25 | $12,251,411 | 1,133,539 | −8.37% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 18, 4:30 pm EDT | Gary Charles RobbChief Business Officer | 10,000 | $116.26 | $1,162,572 | 39,716 | −20.1% | |
| Aug 17, 2026 GForm 4 → | Aug 18, 4:30 pm EDT | Gary Charles RobbChief Business Officer | 125 | — | — | 13,426 | — | |
| Aug 14, 2026 SForm 4 → | Aug 18, 4:30 pm EDT | Sean MaduckSee Remarks | 3,664 | $114.49 | $419,491 | 9,755 | −27.3% | 10b5-1 |
| Aug 14, 2026 MForm 4 → | Aug 18, 4:30 pm EDT | Sean MaduckSee Remarks | 3,664 | $8.27 | $30,301 | 13,419 | — | 10b5-1 |
| Aug 14, 2026 SForm 4 → | Aug 18, 4:30 pm EDT | James N WilsonDirector | 10,000 | $111.43 | $1,114,261 | 1,074,543 | −0.92% | 10b5-1 |
| Aug 12, 2026 GForm 4 → | Aug 14, 4:31 pm EDT | Gary Charles RobbChief Business Officer | 17,530 | — | — | 15,571 | — | |
| Aug 10, 2026 SForm 4 → | Aug 12, 4:27 pm EDT | Sean MaduckSee Remarks | 1,031 | $114.52 | $118,068 | 9,755 | −9.56% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 4:27 pm EDT | Sean MaduckSee Remarks | 1,031 | $8.27 | $8,526 | 10,786 | — | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 12, 4:26 pm EDT | William GuyerChief Development Officer | 16,300 | $113.43 | $1,848,890 | 3,985 | −80.4% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 4:26 pm EDT | William GuyerChief Development Officer | 16,300 | $21.65 | $352,895 | 20,285 | — | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 6, 6:44 pm EDT | William GuyerChief Development Officer | 3,700 | $113.12 | $418,562 | 3,985 | −48.1% | 10b5-1 |
| Aug 4, 2026 MForm 4 → | Aug 6, 6:44 pm EDT | William GuyerChief Development Officer | 3,700 | $21.65 | $80,105 | 7,685 | — | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 5:51 pm EDT | Sean MaduckSee Remarks | 20,305 | $114.70 | $2,329,075 | 9,755 | −67.5% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 5:51 pm EDT | Sean MaduckSee Remarks | 20,305 | $8.27 | $167,922 | 30,060 | — | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 5:48 pm EDT | Joseph Douglas LyonSee Remarks | 1,540 | $114.16 | $175,806 | 5,495 | −21.9% | |
| Jul 30, 2026 SForm 4 → | Aug 3, 4:30 pm EDT | Atabak MokariChief Financial Officer | 80,000 | $114.71 | $9,177,109 | 16,130 | −83.2% | 10b5-1 |
| Jul 30, 2026 MForm 4 → | Aug 3, 4:30 pm EDT | Atabak MokariChief Financial Officer | 80,000 | $23.06 | $1,844,800 | 96,130 | — | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 17, 6:38 pm EDT | James N WilsonDirector | 10,000 | $88.30 | $882,986 | 1,084,543 | −0.91% | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 17, 6:31 pm EDT | Atabak MokariChief Financial Officer | 40,000 | $87.71 | $3,508,277 | 16,130 | −71.3% | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 6:31 pm EDT | Atabak MokariChief Financial Officer | 40,000 | $21.56 | $862,235 | 56,130 | — | 10b5-1 |
| Jul 7, 2026 SForm 4 → | Jul 8, 7:54 pm EDT | William GuyerChief Development Officer | 20,000 | $93.13 | $1,862,530 | 3,985 | −83.4% | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 8, 7:54 pm EDT | William GuyerChief Development Officer | 20,000 | $21.65 | $433,000 | 23,985 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:44 pm EDT | Sean MaduckSee Remarks | 25,000 | $88.35 | $2,208,737 | 9,755 | −71.9% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 4:44 pm EDT | Sean MaduckSee Remarks | 25,000 | $8.27 | $206,750 | 34,755 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 18, 7:47 pm EDT | Gary Charles RobbChief Business Officer | 17,493 | — | — | 182,507 | — | |
| Sep 14, 2026 MForm 4 → | Sep 16, 4:30 pm EDT | Joseph Douglas LyonSee Remarks | 10,000 | — | — | 4,167 | — | 10b5-1 |
| Sep 2, 2026 MForm 4 → | Sep 3, 9:02 pm EDT | Roberto Wandenkolk VieiraPresident, Oncology | 58,333 | — | — | 141,667 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 9:16 pm EDT | Sean MaduckSee Remarks | 25,000 | — | — | 66,986 | — | 10b5-1 |
| Aug 26, 2026 MForm 4 → | Aug 28, 4:30 pm EDT | Kimberly ParkDirector | 30,000 | — | — | 30,000 | — | |
| Aug 25, 2026 MForm 4 → | Aug 27, 4:30 pm EDT | Sean MaduckSee Remarks | 30,955 | — | — | 169,045 | — | 10b5-1 |
| Aug 14, 2026 MForm 4 → | Aug 18, 4:30 pm EDT | Sean MaduckSee Remarks | 3,664 | — | — | 91,986 | — | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 4:27 pm EDT | Sean MaduckSee Remarks | 1,031 | — | — | 95,650 | — | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 4:26 pm EDT | William GuyerChief Development Officer | 16,300 | — | — | 110,000 | — | 10b5-1 |
| Aug 4, 2026 MForm 4 → | Aug 6, 6:44 pm EDT | William GuyerChief Development Officer | 3,700 | — | — | 126,300 | — | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 5:51 pm EDT | Sean MaduckSee Remarks | 20,305 | — | — | 96,681 | — | 10b5-1 |
| Jul 30, 2026 MForm 4 → | Aug 3, 4:30 pm EDT | Atabak MokariChief Financial Officer | 80,000 | — | — | 95,833 | — | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 6:31 pm EDT | Atabak MokariChief Financial Officer | 40,000 | — | — | 175,833 | — | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 8, 7:54 pm EDT | William GuyerChief Development Officer | 20,000 | — | — | 130,000 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 4:44 pm EDT | Sean MaduckSee Remarks | 25,000 | — | — | 116,986 | — | 10b5-1 |